OUTLOOK THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
OUTLOOK THERAPEUTICS, INC. (OTLK) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 269.48 thousand shares for the 12-month period ending 2020-09-30, per its 10-K filed 2020-12-23.
Discontinued › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2020-12-23
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-09-30 was 2.14K shares, a 85.26% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-06-30 was 55.08K shares, a 65.45% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2020-03-31 was 55.67K shares.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2019-12-31 was 156.58K shares, a 55.03% decline year-over-year.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2020 was 269.48K shares, a 21.09% increase from fiscal 2019.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2019 was 222.54K shares, a 748.20% increase from fiscal 2018.
- OUTLOOK THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2018 was 26.24K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2020-09-30 | 2.14K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | 57.22K shares derived: sum of 2 quarters · filed 2020-12-23 | 112.89K shares derived: sum of 3 quarters · filed 2020-12-23 | 269.48K shares 10-K · filed 2020-12-23 |
| 2020-06-30 | 55.08K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-08-14 | 110.76K shares derived: sum of 2 quarters · filed 2020-08-14 | 267.34K shares 10-Q · filed 2020-08-14 | 281.84K shares derived: sum of 4 quarters · filed 2020-12-23 |
| 2020-03-31 | 55.67K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2020-05-15 | 212.26K shares 10-Q · filed 2020-05-15 | 226.76K shares derived: sum of 3 quarters · filed 2020-12-23 | 386.18K shares derived: sum of 4 quarters · filed 2020-12-23 |
| 2019-12-31 | 156.58K shares 10-Q · filed 2020-02-14 | 171.08K shares derived: sum of 2 quarters · filed 2020-12-23 | 330.50K shares derived: sum of 3 quarters · filed 2020-12-23 | 30.96K shares derived: sum of 4 quarters · filed 2020-12-23 |
| 2019-09-30 | 14.50K shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-12-23 | 173.92K shares derived: sum of 2 quarters · filed 2020-12-23 | -125.62K shares derived: sum of 3 quarters · filed 2020-12-23 | 222.54K shares 10-K · filed 2020-12-23 |
| 2019-06-30 | 159.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-08-14 | -140.12K shares derived: sum of 2 quarters · filed 2019-08-14 | 208.04K shares 10-Q · filed 2019-08-14 | |
| 2019-03-31 | -299.54K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2019-05-15 | 48.62K shares 10-Q · filed 2019-05-15 | ||
| 2018-12-31 | 348.16K shares 10-Q · filed 2019-02-14 | |||
| 2018-09-30 | 26.24K shares 10-K · filed 2019-12-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |